Antibodies - Bispecific Antibodies Target Tumors While Sparing Healthy Tissue
View as a Web Page
News Medical
 
  Antibodies Antibodies logo  
  The latest antibodies news from News Medical  
 

Develop Better Tissue Analysis Strategies with MultiplexingDevelop Better Tissue Analysis Strategies with Multiplexing

As tissue analysis grows more complex, traditional IHC workflows can limit the depth of biological insight. This practical eBook explores how multiplexing enables simultaneous biomarker analysis, improved spatial context, and streamlined workflows.

Discover panel design strategies, validation best practices, and real-world applications for advancing tissue-based research.

Download Your Free eBook
 
   Bispecific Antibodies Target Tumors While Sparing Healthy TissueBispecific Antibodies Target Tumors While Sparing Healthy Tissue
 
A new generation of bispecific antibodies effectively targets cancer cells, minimizing toxicity and enhancing treatment precision in preclinical studies.
 
   Alzheimer’s monoclonal antibodies fail to deliver meaningful resultsAlzheimer’s monoclonal antibodies fail to deliver meaningful results
 
Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps in current therapeutic approaches.
 
 New antibody therapy promotes nerve regeneration after spinal cord injury
 
New antibody therapy promotes nerve regeneration after spinal cord injuryAn international research group recently demonstrated that the antibody NG101 promotes the regeneration of damaged spinal cord tissue.
 
 
 Antibody profiles offer insights into long Covid cognitive symptoms
 
Antibody profiles offer insights into long Covid cognitive symptomsPersistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined.
 
 
 Antibodies targeting GPNMB may slow Parkinson's disease progression
 
Antibodies targeting GPNMB may slow Parkinson's disease progressionMonoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's disease (PD).
 
 
 Experimental vaccine triggers broadly neutralizing HIV antibodies in macaques
 
Experimental vaccine triggers broadly neutralizing HIV antibodies in macaquesFor years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutating virus.
 
 
 Antibody-Directed Xenophagy Pathway Blocks Intracellular Infections From Spreading
 
Antibody-Directed Xenophagy Pathway Blocks Intracellular Infections From SpreadingScientists have revealed the process by which cells can internally digest bacteria and viruses.
 
 
 New antibody mechanism selectively suppresses harmful immune responses
 
New antibody mechanism selectively suppresses harmful immune responsesThe immune system is our frontline protection against infection, continually searching for and destroying unknown pathogens.
 
 
 Antibody fragment offers safer alternative for Alzheimer disease treatment
 
Antibody fragment offers safer alternative for Alzheimer disease treatmentIn 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (Leqembi, from Biogen) and donanemab (KisunlaTM, from Eli Lilly and Company), both based on immunotherapy (the use of molecules from the immune system to treat diseases).
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026